Nienke van Rooij
- Immunology top 2%
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 3
- Oncology top 2%
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 8
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 2
- Hematology top 10%
-
- vaccines and immunoinformatics approaches 2
-
- Virus-based gene therapy research 3
- Co-authors
- Ton N. SchumacherMireille ToebesMarit M. van BuurenShalin H. NaikLeïla PeriéRob J. de BoerCarmen GerlachArno Velds
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Nienke van Rooij
21 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 1.3k
- Oncology 1.2k
- Cancer Research 201
- Hematology 109
- Molecular Biology 611
Countries citing papers authored by Nienke van Rooij
This map shows the geographic impact of Nienke van Rooij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nienke van Rooij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nienke van Rooij more than expected).
Fields of papers citing papers by Nienke van Rooij
This network shows the impact of papers produced by Nienke van Rooij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nienke van Rooij. The network helps show where Nienke van Rooij may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nienke van Rooij, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 24 | |
| 8 | 2020 | 14 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 250 | |
| 11 | 2016 | 323 | |
| 12 | 2016 | 12 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 42 | |
| 15 | 2013 | 269 | |
| 16 | 2013 | 2 | |
| 17 | 2013 | 282 | |
| 18 | 2013 | 2 | |
| 19 | 2013 | 7 | |
| 20 | Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanomabreakdown → | 2013 | 624 |
About Nienke van Rooij
Nienke van Rooij is a scholar working on Immunology, Oncology and Virology, having authored 22 papers that have together received 1.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Immune Cell Function and Interaction (5 papers), Virus-based gene therapy research (3 papers), T-cell and B-cell Immunology (3 papers), vaccines and immunoinformatics approaches (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.2k citations) and Cancer Research (201 citations). Nienke van Rooij has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include Ton N. Schumacher, Mireille Toebes, Marit M. van Buuren, Shalin H. Naik, Leïla Perié, Rob J. de Boer, Carmen Gerlach, Arno Velds, Sander Kelderman and Bianca Heemskerk. Their work appears in journals such as Nature, Science and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.